Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug;212(3):457-465.
doi: 10.1007/s10549-025-07735-1. Epub 2025 Jun 3.

Insurer and patient costs for repeat breast surgery after initial lumpectomy for breast cancer

Sam E Wing  1 , Yuki Liu  2 , Feibi Zheng  2   3 , Naomi C Hamm  2 , Nayana S Dekhne  4 , Jesse C Selber  4
Affiliations

Insurer and patient costs for repeat breast surgery after initial lumpectomy for breast cancer

Sam E Wing et al. Breast Cancer Res Treat. 2025 Aug.

Abstract

Purpose: ~ 14-25% of patients who undergo a primary lumpectomy for the treatment of breast cancer require a reoperation due to adverse outcomes like positive surgical margins or early cancer recurrence, adding burden to the patients, providers, and payors. We analyze the economic impact of patients who require repeat breast tissue resection as part of their treatment following initial resection.

Methods: We utilized the Merative™ MarketScan Research Database to identify a cohort of women in the United States who received an index lumpectomy between 2016 and 2021 and identified their healthcare encounters one year postoperatively, including any repeat lumpectomies or mastectomies, as well as the use of any intraoperative adjuncts (e.g. localization methods or frozen sections).

Results: Among 8,869 patients with a primary lumpectomy, 25% (n = 2197) underwent a second surgery, of which 75% (n = 1644) was a repeat lumpectomy and 25% (n = 553) was a mastectomy. Median healthcare expenditure for primary lumpectomy plus one year follow up was $55,985 USD ($2,500 out-of-pocket). Among patients with secondary procedures, median healthcare expenditure from primary lumpectomy plus one year follow up was $63,416 ($3,005 out-of-pocket) for repeat lumpectomy and $87,961 ($3,100 out-of-pocket) for subsequent mastectomy patients. Repeat procedures were more common among patients who did not receive an intraoperative adjunct for lesion localization or margin assessment.

Conclusion: While lumpectomy is the most common surgery for early-stage breast cancer, it often is not definitive, which can result in large added financial and operational burdens. Patient risk stratification and intraoperative adjuncts are needed to minimize risk of reoperation.

Keywords: Breast cancer; Economic evaluation; Lumpectomy; Surgery.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of interest: SW, YL, and FZ are employees of Intuitive Surgical. For the remaining authors, no relevant conflicts are declared. Ethical approval: As this was an observational study of de-identified patients in the MarketScan database, Institutional Review Board approval and consent were exempt (in accordance with the Health Insurance Portability and Accountability Act Privacy Rule). An IRB exemption was approved by the wcg™ IRB (#13931684).

Figures

Fig. 1
Fig. 1
Patient enrollment and exclusion flowchart
Fig. 2
Fig. 2
Reoperation rates and one-year post index lumpectomy median total costs
Fig. 3
Fig. 3
Reoperation rates by year of index lumpectomy
Fig. 4
Fig. 4
Rates of intraoperative adjunct usage
Fig. 5
Fig. 5
Reoperation rates by intraoperative adjunct usage
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Globocan 2022. In.: International Agency for Research on Cancer; 2024.
    1. Cancer Trends Progress Report: Stage at Diagnosis. In.: National Cancer Institute; 2024.
    1. Breast Cancer Facts & Figures (2019) 2019–2020. American Cancer Society, In.
    1. de Boniface J, Szulkin R, Johansson ALV (2021) Survival after breast conservation vs mastectomy adjusted for comorbidity and socioeconomic status: A Swedish national 6-year follow-up of 48 986 women. JAMA Surg 156(7):628–637 - PMC - PubMed
    1. Wilke LG, Czechura T, Wang C, Lapin B, Liederbach E, Winchester DP, Yao K (2014) Repeat surgery after breast conservation for the treatment of stage 0 to II breast carcinoma: a report from the national cancer data base, 2004–2010. JAMA Surg 149(12):1296–1305 - PubMed

LinkOut - more resources